219 related articles for article (PubMed ID: 32060719)
1. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
Shuai Y; Li C; Zhou X
Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
[TBL] [Abstract][Full Text] [Related]
2. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
3. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis.
Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C
Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371
[TBL] [Abstract][Full Text] [Related]
4. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
He XK; Su TT; Si JM; Sun LM
Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
[TBL] [Abstract][Full Text] [Related]
5. The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta‑analysis.
Wu HD; Zhang JJ; Zhou BJ
Clin Transl Oncol; 2021 Feb; 23(2):275-282. PubMed ID: 32507907
[TBL] [Abstract][Full Text] [Related]
6. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
[TBL] [Abstract][Full Text] [Related]
7. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
[TBL] [Abstract][Full Text] [Related]
8. Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
Mekuria AN; Ayele Y; Tola A; Mishore KM
J Diabetes Res; 2019; 2019():7676909. PubMed ID: 31828167
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
[TBL] [Abstract][Full Text] [Related]
10. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature.
Tseng CH
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356646
[TBL] [Abstract][Full Text] [Related]
12. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
[TBL] [Abstract][Full Text] [Related]
13. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
14. Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies.
Li L; Huang J; Huang T; Yao J; Zhang Y; Chen M; Shentu H; Lou H
Int J Endocrinol; 2023; 2023():5892731. PubMed ID: 36915376
[TBL] [Abstract][Full Text] [Related]
15. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
[TBL] [Abstract][Full Text] [Related]
16. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
[No Abstract] [Full Text] [Related]
17. Gastric cancer. Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer.
Greenhill C
Nat Rev Gastroenterol Hepatol; 2015 Mar; 12(3):124. PubMed ID: 25623201
[No Abstract] [Full Text] [Related]
18. Effect of Metformin Use on Survival and Recurrence Rate of Gastric Cancer After Gastrectomy in Diabetic Patients: A Systematic Review and Meta-analysis of Observational Studies.
Bahardoust M; Mousavi S; Moezi ZD; Yarali M; Tayebi A; Olamaeian F; Tizmaghz A
J Gastrointest Cancer; 2024 Mar; 55(1):65-76. PubMed ID: 37526857
[TBL] [Abstract][Full Text] [Related]
19. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
20. Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis.
Xin WX; Fang L; Fang QL; Zheng XW; Ding HY; Huang P
Medicine (Baltimore); 2018 Mar; 97(9):e0035. PubMed ID: 29489653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
